☰

Geoffrey D. Wool, Ph.D. - Publications

Affiliations: 
2008 University of Chicago, Chicago, IL 
Area:
Pathology, Medicine and Surgery, Molecular Biology
Tree Info Grants Similar researchers PubMed Report error

8 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Wool GD. Apolipoprotein A-I mimetic peptides in dyslipidemia and atherosclerosis: an investigational timeline Clinical Lipidology. 10: 467-473. DOI: 10.2217/clp.15.35  0.411
2014 Wool GD, Reardon CA, Getz GS. Mimetic peptides of human apoA-I helix 10 get together to lower lipids and ameliorate atherosclerosis: is the action in the gut? Journal of Lipid Research. 55: 1983-5. PMID 25085258 DOI: 10.1194/Jlr.E053538  0.624
2011 Wool GD, Cabana VG, Lukens J, Shaw PX, Binder CJ, Witztum JL, Reardon CA, Getz GS. 4F Peptide reduces nascent atherosclerosis and induces natural antibody production in apolipoprotein E-null mice. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 25: 290-300. PMID 20876212 DOI: 10.1096/Fj.10-165670  0.609
2010 Getz GS, Wool GD, Reardon CA. HDL apolipoprotein-related peptides in the treatment of atherosclerosis and other inflammatory disorders. Current Pharmaceutical Design. 16: 3173-84. PMID 20687877 DOI: 10.2174/138161210793292492  0.627
2010 Getz GS, Wool GD, Reardon CA. Biological properties of apolipoprotein a-I mimetic peptides. Current Atherosclerosis Reports. 12: 96-104. PMID 20425244 DOI: 10.1007/S11883-010-0097-4  0.636
2009 Wool GD, Vaisar T, Reardon CA, Getz GS. An apoA-I mimetic peptide containing a proline residue has greater in vivo HDL binding and anti-inflammatory ability than the 4F peptide. Journal of Lipid Research. 50: 1889-900. PMID 19433476 DOI: 10.1194/Jlr.M900151-Jlr200  0.616
2009 Getz GS, Wool GD, Reardon CA. Apoprotein A-I mimetic peptides and their potential anti-atherogenic mechanisms of action. Current Opinion in Lipidology. 20: 171-5. PMID 19373084 DOI: 10.1097/Mol.0B013E32832Ac051  0.613
2008 Wool GD, Reardon CA, Getz GS. Apolipoprotein A-I mimetic peptide helix number and helix linker influence potentially anti-atherogenic properties. Journal of Lipid Research. 49: 1268-83. PMID 18323574 DOI: 10.1194/Jlr.M700552-Jlr200  0.621
Show low-probability matches.